NCT03823547 Future Optimal Research and Care Evaluation
| NCT ID | NCT03823547 |
| Status | Recruiting |
| Phase | — |
| Sponsor | J.M. ten Berg |
| Condition | Acute Coronary Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 99,999 participants |
| Start Date | 2015-01-01 |
| Primary Completion | 2050-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 99,999 participants in total. It began in 2015-01-01 with a primary completion date of 2050-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Rationale: Acute coronary syndrome (ACS) is the leading cause of death worldwide. To improve cardiovascular care, research is needed. Current guidelines are mainly based on well controlled RCT's, though evaluation of the impact of such RCT's in the real world is missing. In order to evaluate the impact and to overcome certain limitations of RCT's, a more practical approach is required. In this sense the use of nonrandomized observational studies is an important tool for determining the effectiveness of a therapy in routine clinical practice. One way to gain insight in characteristics of patients presenting in daily clinical practice, is to simply register these characteristics in a prospective manner with adequate follow up. Objective: To create an ongoing registry for evaluation of clinical long-term impact of diagnostics, various treatments and devices used for ACS, for research and evaluation of quality of care and to evaluate and improve regional quality of care and cooperation between PCI and non-PCI centers.
Eligibility Criteria
Inclusion Criteria: * All patients presenting with ACS * Age ≥ 18 years Exclusion Criteria: * No oral or signed informed consent available.
Contact & Investigator
Johan Dekker, Drs.
STUDY CHAIR
St. Antonius Hospital
Frequently Asked Questions
Who can join the NCT03823547 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Coronary Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03823547 currently recruiting?
Yes, NCT03823547 is actively recruiting participants. Contact the research team at d.chanpinyin@antoniusziekenhuis.nl for enrollment information.
Where is the NCT03823547 trial being conducted?
This trial is being conducted at Apeldoorn, Netherlands, Arnhem, Netherlands, Ede, Netherlands, Tiel, Netherlands.
Who is sponsoring the NCT03823547 clinical trial?
NCT03823547 is sponsored by J.M. ten Berg. The principal investigator is Johan Dekker, Drs. at St. Antonius Hospital. The trial plans to enroll 99,999 participants.